胰腺神经内分泌肿瘤(pNETs):MDCT特征在鉴别组织病理学分级中的预测价值
回顾性分析61例患者65个经病理证实的胰腺神经内分泌肿瘤的MDCT特征,并与组织病理学分级对照。研究发现年龄、最长肿瘤径、异质性、延迟期低密度灶、分叶、血管包绕、邻近器官侵犯、肝转移及淋巴结病变等与分级显著相关;作者提出含6项参数的影像标准,6项全部满足时预测G2、3的特异度100%、准确率70.1%,满足至少4项时准确率84.21%、敏感度80.00%、特异度87.5%。
要点
- 肿瘤最长径>33 mm、动脉期相对(R)强化≤1.33及相对(D)强化≤16.5提示G2、3。
- 动脉期高强化面积百分比≤75%、血管包绕和分叶为分级预测的另3项参数。
- 6项参数全部满足预测G2、3特异度100%,满足至少4项时准确率84.21%。
核心结论
- 作者提出了一套对胰腺神经内分泌肿瘤组织病理学分级具有高特异度和准确率的影像标准,可用于预测分级。
研究设计与样本
- 回顾性研究纳入61例患者共65个经组织病理学证实的胰腺神经内分泌肿瘤病灶,评估其MDCT影像特征并与病理分级对照。
- 按病理分为G1组32个(49.2%)与G2、3组33个(50.8%);患者平均年龄50.70±14.28岁,男性30例(49.2%)。
关键影像表现/征象
- 异质性、延迟期低密度灶、分叶、血管包绕、邻近器官侵犯、肝转移(存在及数目)、短轴>10 mm的淋巴结肿大及病理性淋巴结大小与分级显著相关。
- 年龄(p=0.006)、最长肿瘤径(p=0.006)、相对(R)强化(p=0.05)、相对(D)强化(p=0.02)及动脉期高强化面积百分比(p<0.0001)与分级显著相关。
诊断标准与关键数值
- 作者提出的6项参数为:肿瘤大小>33 mm、动脉期相对(R)肿瘤强化≤1.33、动脉期相对(D)肿瘤强化≤16.5、动脉期高强化面积百分比≤75%、血管包绕、分叶。
- 6项全部满足(6/6)预测G2、3的特异度100%、准确率70.1%。
- 满足至少4项时准确率最高(84.21%),敏感度80.00%、特异度87.5%、PPV 83.33%、NPV 84.85%。
临床应用与阅片要点
- 阅片时可对照上述6项MDCT参数评估胰腺神经内分泌肿瘤,辅助预测病理分级。
- 满足至少4项参数时预测G2、3的准确率最高,6项全部满足时特异度达100%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the correlation between multiple detector computed tomography (MDCT) features of pancreatic neuroendocrine tumors (pNETs) and histopathologic grade and find valuable imaging criteria for grade prediction.
MATERIAL AND METHODS: MDCT of 61 patients with 65 masses, which pNETs were approved histopathologically, underwent revision retrospectively. Each MDCT was evaluated for various radiologic characteristics. Absolute and relative (R: tumor/pancreas, D: tumor-pancreas) tumor enhancements were calculated in multiple post contrast phases.
RESULTS: 61 patients [mean age = 50.70 ± 14.28 y/o and 30(49.2%) were male] were evaluated and classified into 2 groups histopathologically: G1: 32 (49.2%) and G2,3: 33 (50.8%). Significant relationships were observed between histopathologic tumor grade regarding age (p = 0.006), the longest tumor size (p = 0.006), presence of heterogeneity (p < 0.0001), hypodense foci in delayed phase (p = 0.004), lobulation (p = 0.002), vascular encasement (p < 0.0001), adjacent organ invasion (p = 0.01), presence (p < 0.0001) and number (0.02) of liver metastases, presence of lymphadenopathy with short axis of more than 10 mm (LAP) (p = 0.008), pathologic lymph node size (p = 0.004), relative (R and D) (p = 0.05 and 0.02, respectively), and percentage of arterial hyper-enhancing area (p = <0.0001). Tumor grades, however, had no significant relationship with gender, tumor location, tumor outline, calcification, cystic change, or pancreatic (PD) or biliary duct (BD) dilation (p = 0.21, 0.60, 0.05, 0.05 1, 0.10, and 0.51, respectively). Then, we suggested a novel imaging criteria consisting of six parameters (tumor size > 33 mm, relative (R) tumor enhancement in arterial phase ≤ 1.33, relative (D) tumor enhancement in arterial phase ≤ 16.5, percentage of arterial hyper-enhancing area ≤ 75%, vascular encasement, and lobulation), which specificity and accuracy of combination of all findings (6/6) for predicting G2,3 were 100% and 70.1%, respectively. The highest accuracy (84.21%) was seen in combinations of at least 4 of 6 findings, with 80.00% sensitivity, 87.5% specificity, 83.33% PPV, and 84.85% NPV.
CONCLUSION: We suggested reliable imaging criteria with high specificity and accuracy for predicting the histopathologic grade of pNETs.
引用
- Salahshour F, Mehrabinejad MM, Zare Dehnavi A, et al. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades. Abdom Radiol (NY). 2020. PMID: 31897681. doi:10.1007/s00261-019-02372-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。